Department of Allergy/Clinical Immunology, Kaiser Permanente Medical Center, Los Angeles, Calif.
Department of Allergy, Kaiser Permanente Medical Center, Gardena, Calif.
J Allergy Clin Immunol Pract. 2015 Jul-Aug;3(4):547-52. doi: 10.1016/j.jaip.2015.02.002. Epub 2015 Mar 7.
A new Healthcare Effectiveness Data and Information Set (HEDIS) asthma quality-of-care measure designed to quantify patient adherence to asthma controller medication has been implemented. The relationship between this measure and asthma outcomes is unknown.
To examine the relationship between the HEDIS Medication Management for people with Asthma (MMA) measure and asthma outcomes.
Administrative data identified 30,040 patients who met HEDIS criteria for persistent asthma during 2012. These patients were classified as compliant or noncompliant with the MMA measure at the 75% and 50% threshold, respectively. The association between MMA compliance in 2012 and asthma outcomes in 2013 was determined.
Patients who were 75% or 50% MMA compliant in 2012 showed no clinically meaningful difference in asthma-related hospitalizations, emergency department visits, or rescue inhaler dispensing in 2013 compared with those who were noncompliant. Stepwise comparison of patients who were 75% or more, 50% to 74%, and less than 50% MMA compliant showed no meaningful difference in asthma outcomes between groups.
Compliance with the HEDIS MMA measure is not related to improvement in the asthma outcomes assessed (rescue inhaler dispensing, asthma-coded hospitalizations, or asthma-coded emergency department visits).
为了量化患者对哮喘控制药物的依从性,新的医疗保健效果数据和信息集(HEDIS)哮喘护理质量措施已经实施。该措施与哮喘结果之间的关系尚不清楚。
研究 HEDIS 哮喘患者药物管理(MMA)措施与哮喘结果之间的关系。
行政数据确定了 2012 年符合持续哮喘 HEDIS 标准的 30040 名患者。这些患者分别被归类为在 75%和 50%的阈值下符合或不符合 MMA 措施。确定了 2012 年 MMA 合规性与 2013 年哮喘结果之间的关联。
2012 年符合 75%或 50%MMA 标准的患者与不符合标准的患者相比,在 2013 年的哮喘相关住院治疗、急诊就诊或急救吸入器配药方面没有明显差异。对符合 75%或更高、50%至 74%以及低于 50%MMA 标准的患者进行逐步比较,各组之间的哮喘结果无明显差异。
遵守 HEDIS MMA 措施与评估的哮喘结果(急救吸入器配药、哮喘编码住院或哮喘编码急诊就诊)的改善无关。